
EUSA Pharma appoints chief executive and director
pharmafile | April 22, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Bryan Morton, Eusa Pharma, Göran Ando, Lee Morley
Recently-established UK-based EUSA Pharma has confirmed the appointment of Lee Morley as its chief executive and Dr Göran Ando (pictured) as a non-executive director.
Also Bryan Morton who established EUSA Pharma as founder and first chief executive – will now become executive chairman.
Morley joins from Jazz Pharmaceuticals where he was vice president and head of commercial for Europe and international markets. At Jazz he had responsibility for the original EUSA Pharma business following its acquisition in 2012, until the recent launch of EUSA as a newly-established firm.
Lee has extensive commercial experience gained over 20 years in the pharma industry. Previously, he held several senior commercial positions at EUSA and also held a number of management roles in sales and marketing at Merck, including UK national sales manager.
Ando is senior advisor with EUSA Pharma’s lead shareholder, Essex Woodlands. He has over 35 years’ experience of the pharma industry which has been spent in a variety of senior international roles. He is currently chairman of Novo Nordisk.
“We are delighted to welcome both Lee and Göran to EUSA Pharma during this exciting time in the development of the company,” says Morton.
Related Content

EUSA Pharma gets FDA green light to evaluate IL-6 inhibitor siltuximab in COVID-19 patients
Efforts push on to discover an effective treatment for COVID-19 in more than 100 different …

EUSA Pharma’s COVID-19 drug improves or stabilises respiratory condition in 76% of patients
EUSA Pharma has unveiled promising preliminary findings from an interim analysis of siltuximab in the …

EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications
Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the …






